ISCO
International Stem Cell CORP · Healthcare · Market cap $2.1M
Insiders sold $10K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Sep 15, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$10K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Sep 15, 2026
MAIER PAUL V
International Stem Cell CORP (ISCO) has 1 SEC Form 4 filing (1 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Sep 15, 2026.
Inside the rolling window, 1 insider at International Stem Cell CORP reported no open-market purchases and 1 open-market sale totaling $10K. The most recent open-market filing is a sale of 32,802 shares by Director MAIER PAUL V, dated Sep 11, 2026, worth $10K.
- Industry:Biotechnology
- CEO:Andrey Semechkin
- Employees:33
- HQ:San Diego, CA, US
- IPO:2007-05-01
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Sale | 32,802 | $10K | Sep 15 | -18.8% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does ISCO have?
International Stem Cell CORP (ISCO) has 1 SEC Form 4 filing (1 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Sep 15, 2026.
When was the most recent SEC Form 4 filing for ISCO?
The most recent Form 4 filing for ISCO on Tracefour is dated Sep 15, 2026.
What is the net insider flow at ISCO over the last 6 months?
Over the trailing 180 days, insiders at ISCO have net sold $10K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ISCO in the current window?
Inside the rolling window, insiders at ISCO bought $0 and sold $10K based on SEC Form 4 filings.
Can I get alerts for ISCO insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at International Stem Cell CORP (ISCO). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
International Stem Cell CORP is in the Healthcare sector.